Molecular roles for PRLR signaling in expansion of maternal β-cells during pregnancy
THURSDAY, May 26, 2016 (HealthDay News) — Prolactin receptor (PRLR) signaling plays a role in expansion of maternal β-cells during pregnancy, according to a study published online May 23 in Diabetes.
Ronadip R. Banerjee, M.D., from the Stanford University School of Medicine in California, and colleagues generated a ‘floxed’ Prlr allele that allowed conditional loss of PRLR in β-cells in order to examine the in vivo requirement for PRLR signaling.
The researchers found that PRLR signaling loss in β-cells resulted in gestational diabetes mellitus (GDM), and in reduced proliferation of β-cells and failure to expand β-cell mass during pregnancy. Expression of the transcription factor Foxm1, both G1/S and G2/M cyclins, tryptophan hydroxylase 1, and islet serotonin production were impaired with targeted PRLR loss in maternal β-cells in vivo. PRLR signaling was also required for the transient gestational expression of the MafB transcription factor within a subset of β-cells in pregnancy. GDM was also produced with deletion of MafB in maternal β-cells; inadequate β-cell expansion was accompanied by failure to induce PRLR-dependent target genes, which regulate proliferation of β-cells.
“These results unveil molecular roles for PRLR signaling in orchestrating the physiologic expansion of maternal β-cells during pregnancy,” the authors write.
Full Text (subscription or payment may be required)
Copyright © 2016 HealthDay. All rights reserved.
